Biden’s State of the Union highlights healthcare wins in cancer White House announces ARPA-H precision cancer therapy program and patient navigation commitments

Argonne National Laboratory receives $22M from ARPA-H to accelerate cancer therapy, vaccine discoveries using AI

The U.S. Department of Energy’s Argonne National Laboratory will use its world-leading capabilities in artificial intelligence and high-performance computing to research novel ways to fight cancer and advance vaccine discovery.

November 22, 2024

Vol.50 No.44

In Brief

Qure.ai completes $65M Series D funding round

Qure.ai has announced the completion of a $65 million Series D funding round. The investment will expedite expansion into the U.S. market and other countries, increase investment in foundational AI models, and enable complementary med-tech company acquisitions.

October 04, 2024

Vol.50 No.37

Guest Editorial

Group chairs propose funding strategy to jump-start correlative studies

The National Academy of Medicine recognized the value of correlative science in publicly funded clinical trials in 2010, recommending “the incorporation of innovative science into cancer clinical trials through the support and use of biorepositories.”

September 20, 2024

Vol.50 No.35

By Peter J. O'Dwyer

Funding Opportunities

DOD Glioblastoma Research Program funding opportunities for FY24

The FY24 Defense Appropriations Act provides funding for the Glioblastoma Research Program to support research of high potential impact and exceptional scientific merit to reduce the burden of glioblastoma on service members and their families, veterans, and the American public. The managing agent for the anticipated program announcements/funding opportunities is the CDMRP at the U.S. Army Medical Research and Development Command.

September 20, 2024

Vol.50 No.35

Conversation with The Cancer Letter

A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease

City of Hope has received a $150 million gift from entrepreneurs and philanthropists A. Emmet Stephenson Jr. and his daughter Tessa Stephenson Brand to create a program focused on pancreatic cancer research.

Carolyn Tucker receives President’s Lifetime Achievement Award

Carolyn M. Tucker, Ph.D., received a 2024 President’s Lifetime Achievement Award from the office of U.S. President Joe Biden. Photo credit: Carolyn TuckerCarolyn M. Tucker has received a 2024 President’s Lifetime Achievement Award from the office of President Joe Biden, in recognition of her work to build healthier communities and providing hundreds with power over cancer.

September 13, 2024

Vol.50 No.34

Biden’s State of the Union highlights healthcare wins in cancer

White House announces ARPA-H precision cancer therapy program and patient navigation commitments

YOU MAY BE INTERESTED IN

Argonne National Laboratory receives $22M from ARPA-H to accelerate cancer therapy, vaccine discoveries using AI

Qure.ai completes $65M Series D funding round

Group chairs propose funding strategy to jump-start correlative studies

DOD Glioblastoma Research Program funding opportunities for FY24

A $150M gift enables City of Hope to establish $1M Stephenson Prize in pancreatic cancer research, build research program focused on the disease

Carolyn Tucker receives President’s Lifetime Achievement Award

Renew today!

Subscriber content

Never miss an issue!

Login